Cryoport, Inc. (CKX.F)
Chart Events
Performance Outlook
| Previous Close | 20.20 |
| Open | 23.40 |
| Bid | 23.20 x N/A |
| Ask | 23.60 x N/A |
| Day's Range | 23.40 - 23.40 |
| 52 Week Range | 14.80 - 43.80 |
| Volume | |
| Avg. Volume | 18 |
| Market Cap | 1.16B |
| Beta (5Y Monthly) | 1.24 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.89 |
| Earnings Date | Feb 22, 2023 - Feb 27, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for CKX.F
Related Research
- Simply Wall St.
When Will Cryoport, Inc. (NASDAQ:CYRX) Become Profitable?
Cryoport, Inc. ( NASDAQ:CYRX ) is possibly approaching a major achievement in its business, so we would like to shine...
- Zacks
Syneos Health (SYNH) Signs New Partnership With Cryoport
Syneos Health (SYNH) inks a partnership with Cryoport to deliver seamless integration and insights for key services for cell and gene trial operations to biopharmaceutical customers.
- PR Newswire
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a leading global provider of innovative temperature-controlled supply chain solutions to the life sciences industry focused on the pharmaceutical and cell and gene therapy markets, today announced a new strategic partnership with Syneos Health® (NASDAQ: SYNH), the only fully integrated biopharmaceutical solutions organization purpose-built to accelerate customer success. Both Cryoport and Syneos Health are world leading solutions companies with deep ex
